Skip to content

PostEra vs Vernalis

PostEra logo

PostEra

Medicinal Chemistry powered by Machine Learning

41 employees · est. 2019 · Boston, United States

VS
Vernalis logo

Vernalis

We develop and apply fragment and structure-based methods to solve problems in drug discovery

260 employees · est. 1997 · Cambridge, United Kingdom

Vernalis is the older company (2019 vs 1997); Vernalis is the larger of the two.

Side-by-Side Comparison

PostEra Vernalis
Founded
2019 1997 older
Headquarters
Boston, United States Cambridge, United Kingdom
Employees
41 260 larger
Industry
AI, Biotechnology, Health and Wellness Biotechnology, Pharmaceutical
Funding Stage
Series A Venture round
Total Funding
$24.13M Not tracked yet
Funding Rounds
4 1
Services
AI Platform for Drug Discovery, Medicinal Chemistry, Pharmaceutical Collaborations, Drug Development Drug Discovery Collaboration, Protein Production, Hit Identification and Validation, Lead Optimization, Biophysics and Structural Biology, Chemical Series Evolution
Target Customers
Pharmaceutical Companies, Biotechnology Firms, Medical Research Institutions Pharmaceutical Companies, Biotech Firms, Research Institutions, Drug Discovery Teams
Taxonomy
AI-first BiotechMedicinal ChemistryMachine Learning In Drug DiscoveryWomen’s HealthFertility TreatmentClinical Candidates +9 Fragment-based Drug DiscoveryStructure-based MethodsOncology Drug DiscoveryNeurodegeneration TargetsAnti-infectivesInflammation Drug Discovery +9
Website
postera.ai vernalis.com
PostEra logo

About PostEra

PostEra, founded in 2019, is a pioneering startup at the intersection of AI and biotechnology, headquartered in the United States. The company leverages its proprietary AI platform, Proton, to revolutionize medicinal chemistry, aiming to accelerate the discovery and development of new medicines. Em...

Vernalis logo

About Vernalis

Vernalis, founded in 1997, is a UK-based company operating at the forefront of the Biotechnology and Pharmaceutical industries. With a commitment to advancing drug discovery, their slogan encapsulates their mission: "We develop and apply fragment and structure-based methods to solve problems in drug...

Also comparing in this category

Comparing more than these two?

Get PostEra, Vernalis and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does PostEra compare?

A PDF of PostEra and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

PostEra was founded in 2019, based in Boston, United States, with 41 employees. PostEra, founded in 2019, is a pioneering startup at the intersection of AI and biotechnology, headquartered in the United States. The company leverages its proprietary AI platform, Proton, to revolut. Vernalis was founded in 1997, based in Cambridge, United Kingdom, with 260 employees. Vernalis, founded in 1997, is a UK-based company operating at the forefront of the Biotechnology and Pharmaceutical industries. With a commitment to advancing drug discovery, their slogan encapsulates.
PostEra has raised $24.13M and Vernalis no disclosed funding. Latest stage: PostEra Series A, Vernalis Venture round.
Both work in Biotechnology and Pharmaceutical and list medicinal chemistry among their focus areas.

Compare PostEra with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at PostEra on 14 Sep 2026, and Vernalis on 2 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout